Strive, Inc. is a stock, not an ETF, and it has active sell-side coverage. The $38 central target used here is the average of five current, individually verifiable price targets: H.C. Wainwright at $40 (lowered from $42 on November 6, 2026, Buy), StoneX at $43 (raised from $32 in late October), TD Cowen at $44 (September 21, 2026, Buy), Maxim Group at $37 (raised from $21 on October 12, 2026, Buy), and B. Riley at $27 (lowered from $33 on November 7, 2026, Buy). The arithmetic mean is about $38.2, rounded to a $38 central target, with a verified range of roughly $27 to $44. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The dispersion is striking and reflects genuine disagreement about bitcoin's trajectory and Strive's capital structure. B. Riley cut its target citing a lower bitcoin price assumption (about $82,500) and a larger preferred-stock stack, while H.C. Wainwright's Mike Colonnese kept a Buy and described Strive's "rapid ascent" as one of the leading bitcoin treasury companies as reinforcing a top-pick thesis. No analyst here is ranked, and the $38 average is not an official published consensus — it is a calculated figure and should not be read as a guarantee.
At its most recent close, ASST traded near $21.45, well below its 52-week high of $34.40 but far above its 52-week low of $7.02. Moving to $38 implies about 77% appreciation — by any standard a very large move that would likely require both a rebound in bitcoin and continued conviction in Strive's accumulation strategy.
Strive is a Dallas-based asset manager and bitcoin treasury company. In the third quarter of 2026 it reported net income of roughly $509 million, almost entirely from $533.7 million in unrealized gains on its bitcoin holdings, against only about $2.7 million in revenue. It held 43,124 bitcoin as of October 30 — the fourth-largest corporate treasury behind Strategy, Metaplanet, and Twenty One — and its CEO has framed bitcoin as the company's "hurdle rate." These facts explain why the shares trade less like a conventional financial stock and more like a leveraged wager on bitcoin's price.
Several verified developments support the bullish case. Strive added 8,136 bitcoin in Q3 and a further 15,124 in October alone, and it reported an 18.5% "bitcoin yield" for the quarter — growth in bitcoin per share, the metric management says has driven ASST's outperformance. A cash position of roughly $490 million and about $609 million raised through a SATS perpetual preferred offering give it firepower to keep buying. Management is also exploring expansion into banking, brokerage, decentralized finance (DeFi), reinsurance, and tokenization, which could broaden the revenue base beyond advisory fees and the acquired Semler Scientific medical-device business. If bitcoin resumes its uptrend, Strive's per-share bitcoin value could compound quickly.
The risks are equally concrete. ASST fell more than 30% over the trailing month while bitcoin declined roughly 12%, showing how the shares amplify bitcoin's moves. Reported profit rests on unrealized, mark-to-market gains that can reverse, as the $228 million loss in Q2 2026 demonstrated. The preferred-stock stack has nearly tripled since Q2, and B. Riley estimates it could approach $2.3 billion by year-end with an annual dividend run-rate around $310 million — a meaningful claim on value ahead of common shareholders, alongside rising share counts that dilute each share's bitcoin exposure. Valuation also appears stretched by some measures, and competition from larger treasury holders remains intense.
On a technical basis, $34.40 — the 52-week high — stands out as the nearest major resistance above current levels, and any sustained move toward $38 would likely need to clear it first. The 52-week low of $7.02 marks the opposite extreme and highlights the stock's volatility. In the most recent session, ASST traded in a range of roughly $19.66 to $21.85, with the $20 area acting as a nearby psychological support level. The long-term structure is that of a high-beta, bitcoin-correlated security that has moved dramatically in both directions within a single year.
Analyst price targets typically reflect a roughly 12-month research horizon, though firms differ, and Strive's targets have been revised rapidly — several times in just the past two months — as bitcoin assumptions change. Investors should watch bitcoin's price and Strive's monthly accumulation updates, quarterly bitcoin yield and earnings reports, and any changes to the SATS and SATA preferred programs, which directly affect dilution and the value accruing to common shares. Analyst revisions and the company's progress toward the number-two corporate treasury position are also worth tracking, as is any regulatory development affecting corporate bitcoin ownership.
The $38 central target is a calculated average of five verified analyst targets ranging from $27 to $44, and it implies roughly 77% upside from a share price near $21.45 — a very large move. The bull case rests on Strive's aggressive bitcoin accumulation, its bitcoin-yield framework, and a cash-rich balance sheet, while the bear case centers on bitcoin's volatility, preferred-stock dilution, and profits that are unrealized and reversible. Analyst opinion is unanimous in direction (Buy) but sharply divided in magnitude, which is itself a signal that the outcome depends far more on bitcoin's path than on any single forecast. Investors should treat $38 as a benchmark for debate, not a destination, and monitor bitcoin, Strive's holdings updates, and its capital-raising activity before drawing conclusions.
In my own research process, I often turn to Tickeron's AI Daily Buy/Sell Signals to monitor names like this one. The tool applies artificial intelligence to scan thousands of stocks and ETFs in real time, producing Buy, Sell, or Hold signals based on shifting market conditions and technical patterns. For a volatile, bitcoin-linked stock such as ASST, that kind of ongoing, data-driven oversight can help identify trend changes more efficiently than manual review alone, allowing investors to stay informed as conditions evolve.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ASST saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 63 similar instances where the indicator turned negative. In 57 of the 63 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
ASST moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ASST crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ASST entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ASST's RSI Indicator exited the oversold zone, 23 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASST advanced for three days, in 142 of 163 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
ASST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. ASST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.242) is normal, around the industry mean (2.412). P/E Ratio (-28.942) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.270) among similar stocks. ASST's P/S Ratio (113.636) is very high in comparison to the industry average of (15.694).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers